Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
New and emerging disease modifying therapies for multiple sclerosis.
Saidha S, Eckstein C, Calabresi PA.
Ann N Y Acad Sci. 2012 Jan;1247:117-37. doi: 10.1111/j.1749-6632.2011.06272.x. Epub 2012 Jan 6. Review.
Related citations
Persistent ocular motor manifestations and related visual consequences in multiple sclerosis.
Tilikete C, Jasse L, Vukusic S, Durand-Dubief F, Vardanian C, Pélisson D, Vighetto A.
Ann N Y Acad Sci. 2011 Sep;1233:327-34. doi: 10.1111/j.1749-6632.2011.06116.x.
Pharmacological tests of hypotheses for acquired pendular nystagmus.
Shaikh AG, Thurtell MJ, Optican LM, Leigh RJ.
Ann N Y Acad Sci. 2011 Sep;1233:320-6. doi: 10.1111/j.1749-6632.2011.06118.x.
Modeling the mechanisms of Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis.
Frohman TC, Davis SL, Frohman EM.
Ann N Y Acad Sci. 2011 Sep;1233:313-9. doi: 10.1111/j.1749-6632.2011.06125.x.
Ustekinumab: lessons learned from targeting interleukin-12/23p40 in immune-mediated diseases.
Elliott M, Benson J, Blank M, Brodmerkel C, Baker D, Sharples KR, Szapary P.
Ann N Y Acad Sci. 2009 Dec;1182:97-110. Review.
Heterogeneous, longitudinally stable molecular signatures in response to interferon-beta.
Rani MR, Xu Y, Lee JC, Shrock J, Josyula A, Schlaak J, Chakraborthy S, Ja N, Ransohoff RM, Rudick RA.
Ann N Y Acad Sci. 2009 Dec;1182:58-68.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on